Dr Chris Wynne is happy to report that the second stage of the RACE study has been completed ahead of schedule. This part of the RACE study was looking at administering Herceptin and Perjeta under the skin (rather than IV) to women who are breast cancer survivors. CCST thanks all these volunteers for giving back to the medical community and for hopefully leading to better outcomes for women with Breast cancer in the future.